Skip to content

Stress properties of the patients with Hematologic Malignancies. -Effect of cognitive-behavioral therapy program combines exercise therapy on autonomic nerve function-

Stress properties of the patients with Hematologic Malignancies. -Effect of cognitive-behavioral therapy program combines exercise therapy on autonomic nerve function- - An intervention study to stress attenuation and enhancement of locomotor activity in patients with Hematologic Malignancies.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022141
Enrollment
30
Registered
2016-04-29
Start date
2015-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematologic malignancy

Interventions

Exercise therapy Attention bias modification (ABM) Cognitive behavioral therapy Exercise therapy Placebo ABM Stretching

Sponsors

Saitama Medical University International Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The patients with leukemia and malignant lymphoma who scheduled for chemotherapy or hematopoietic stem cell transplantation, they has been prescribed occupational therapy after the announcement by doctor past two weeks. (2) Any person can be more than 40 minutes sitting at a position holds.

Exclusion criteria

Exclusion criteria: (1) merging the central disease (2) depression and history of mental disorders of anxiety (3) the cognitive decline admit persons (4) a person who has exhibited serious side effects on the autonomic nervous with chemotherapy

Design outcomes

Primary

MeasureTime frame
Profile of Mood States

Secondary

MeasureTime frame
Autonomic nervous system Salivary amylase activity Locomotor activity

Countries

Japan

Contacts

Public ContactKohei koizumi

Saitama Medical University International Medical Center Rehabilitation center

izumiko@saitama-med.ac.jp042-984-4367

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026